• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Will JJ SURGICAL VISION SURVIVE?









JJSV is lead by ABSOLUTE morons that drink the CREDO cool aid. Everyone that was making NO MONEY at other J&J companies jumped over to Surgical Vision because most persons at Surg Vision were making big bucks from the AMO days until the typical J&J company money algorithm kicked in and then the transfers, being totally inept in ophthalmology, were like......."HEY...... I THOUGHT YOU GUYS WERE MAKING BUCKS"??? Those days are over. JJSV is the land of ABSOLUTE MISFITS.....especially Warren and that bug eye'd babe, (FAS) in the south.